CLBT — Recent News Coverage

All news mentioning CLBT in ESEN's AI-graded feed

News stories with CLBT as an affected ticker. Each article is graded by ESEN AI for impact level and direction (up/down/flat) on CLBT. See /coverage/CLBT for the 30-day aggregate.

5 articles Updated: 2026-09-06 13:06 UTC Filter: Ticker: $CLBT
SEEKINGALPHA.COM · 2026-08-13 LOW NEUTRAL CORR0.42

Cellebrite DI Ltd. (CLBT) Q2 2026 Earnings Call Transcript

$CLBT
◈ ESEN AI
Cellebrite (CLBT) released its Q2 2026 earnings call transcript, a scheduled procedural disclosure that provides management commentary on quarterly performance and operational metrics. This type of earnings call publica…
SEEKINGALPHA.COM · 2026-08-13 NEUTRAL NEUTRAL CORR0.42

Cellebrite Q2: This 33% Selloff Looks Like An Overreaction (NASDAQ:CLBT)

$CLBT
◈ ESEN AI
CLBT experienced a sharp 33% post-earnings decline, representing a significant single-session drawdown that reflects market sentiment dislocation rather than fundamental deterioration. The severity of the sell-off relat…
RTTNEWS.COM · 2026-08-13 LOW NEUTRAL CORR0.15

Morning Market Movers: FGI, ARX, CLBT, HLIT See Big Swings

$FGI $ARX $CLBT $HLIT
◈ ESEN AI
This premarket activity report flags four stocks experiencing notable trading volume shifts during early morning hours, but provides no underlying catalyst or fundamental trigger. FGI, ARX, CLBT, and HLIT are noted sole…
FINANCE.YAHOO.COM · 2026-06-20 NEUTRAL BULLISH CORR0.58

Cellebrite (CLBT)’s Total Addressable Market Is Large, Growing, And Likely Understated, According To DA Davidson

$CLBT
◈ ESEN AI
Cellebrite (CLBT) received initiating coverage from DA Davidson with a notably constructive thesis centered on market opportunity underestimation. The analyst perspective emphasizes that the company's total addressable …
FINANCE.YAHOO.COM · 2026-06-19 LOW NEUTRAL CORR0.35

Is Cellebrite DI Ltd. (CLBT) A Good Stock To Buy Now?

$CLBT
◈ ESEN AI
CLBT is the subject of a bullish investment thesis circulating on retail research platforms, with the stock trading near $12.47 as of mid-June. The valuation metrics present a mixed picture: a trailing P/E of 45.75 sugg…
EXPLORE OTHER FILTERS